Language selection

Government of Canada / Gouvernement du Canada

Search

Budget impact analysis guidelines : guidelines for conducting pharmaceutical budget impact analyses for submission to public drug plans in Canada.: H79-1/2007E-PDF

Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.689808&sl=0

Publication information
Department/Agency
  • Canada. Patented Medicine Prices Review Board.
TitleBudget impact analysis guidelines : guidelines for conducting pharmaceutical budget impact analyses for submission to public drug plans in Canada.
Variant title
  • Guidelines for conducting pharmaceutical budget impact analyses for submission to public drug plans in Canada
Publication typeMonograph
Language[English]
Other language editions[French]
Later editionBudget impact analysis guidelines :
FormatDigital text
Electronic document
Note(s)
  • Issued also in French under title: Lignes directrices pour l'analyse de l'incidence du prix d'un médicament : lignes directrices pour l'analyse de l'incidence du prix d'un médicament sur les budgets des régimes d'assurance-médicaments.
  • "Published May 2007."
  • Includes bibliographical references (pages 56-58).
Publishing information
  • [Ottawa] : Patented Medicine Prices Review Board = Conseil d'examen du prix des médicaments brevetés, 2007.
Description1 online resource (i, 58 pages)
ISBN9780662458883
Catalogue number
  • H79-1/2007E-PDF
Edition
  • [First edition].
Subject terms
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.

Page details

Report a problem or mistake on this page
Date modified: